These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression. Yan H; Ma YL; Gui YZ; Wang SM; Wang XB; Gao F; Wang YP Acta Pharmacol Sin; 2014 Aug; 35(8):994-1004. PubMed ID: 25042549 [TBL] [Abstract][Full Text] [Related]
26. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression. Duan Y; Chen Y; Hu W; Li X; Yang X; Zhou X; Yin Z; Kong D; Yao Z; Hajjar DP; Liu L; Liu Q; Han J J Biol Chem; 2012 Jul; 287(28):23667-77. PubMed ID: 22593575 [TBL] [Abstract][Full Text] [Related]
27. Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9). Wang Y; Ye J; Li J; Chen C; Huang J; Liu P; Huang H Cardiovasc Diabetol; 2016 Feb; 15():19. PubMed ID: 26833058 [TBL] [Abstract][Full Text] [Related]
28. The biological relevance of PCSK9: when less is better…. Mbikay M; Chrétien M Biochem Cell Biol; 2022 Jun; 100(3):189-198. PubMed ID: 35263196 [TBL] [Abstract][Full Text] [Related]
29. Proprotein convertase subtilisin/kexin type 9 potentially influences cholesterol uptake in macrophages and reverse cholesterol transport. Shen L; Peng HC; Nees SN; Zhao SP; Xu DY FEBS Lett; 2013 May; 587(9):1271-4. PubMed ID: 23499248 [TBL] [Abstract][Full Text] [Related]
30. RNA therapeutics inactivate PCSK9 by inducing a unique intracellular retention form. Rocha CS; Wiklander OP; Larsson L; Moreno PM; Parini P; Lundin KE; Smith CI J Mol Cell Cardiol; 2015 May; 82():186-93. PubMed ID: 25791168 [TBL] [Abstract][Full Text] [Related]
31. The effects of estrogen on serum level and hepatocyte expression of PCSK9. Guo W; Fu J; Chen X; Gao B; Fu Z; Fan H; Cui Q; Zhu X; Zhao Y; Yang T; Fan D; Zhou H Metabolism; 2015 Apr; 64(4):554-60. PubMed ID: 25665485 [TBL] [Abstract][Full Text] [Related]
32. Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia. Si-Tayeb K; Idriss S; Champon B; Caillaud A; Pichelin M; Arnaud L; Lemarchand P; Le May C; Zibara K; Cariou B Dis Model Mech; 2016 Jan; 9(1):81-90. PubMed ID: 26586530 [TBL] [Abstract][Full Text] [Related]
33. Proprotein convertase subtilisin kexin9 (PCSK9): a novel target for cholesterol regulation. Basak A; Palmer-Smith H; Mishra P Protein Pept Lett; 2012 Jun; 19(6):575-85. PubMed ID: 22519528 [TBL] [Abstract][Full Text] [Related]